IMMUNE CHECKPOINT INHIBITORS
Clinical trials for IMMUNE CHECKPOINT INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITORS trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Pre-Surgery combo aims to wipe out colon cancer cells
Disease control OngoingThis study is testing a new treatment approach for people with a common type of locally advanced colon cancer. Before having standard surgery, participants receive a combination of an immunotherapy drug (tislelizumab) and two chemotherapy drugs (oxaliplatin and capecitabine). The…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Research probes survival gap for native americans on cancer immunotherapy
Knowledge-focused OngoingThis study looks back at medical records to understand how well immunotherapy cancer drugs work for American Indian patients compared to White patients. Researchers will analyze survival times, side effects, and cancer-related deaths in 72 patients who were treated between 2015 a…
Matched conditions: IMMUNE CHECKPOINT INHIBITORS
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC